We have embarked on a series of initiatives at NIH in recent years to enhance the quality, efficiency, accountability, and transparency of our supported clinical research. While we are all making great progress, our concerns about clinical trials that are overly complex, have small sample sizes, or rely on surrogate end points that lack clinical relevance remain. One resource to help address these concerns is the NIH Research Methods Resources website that NIH’s Office of Disease Prevention (ODP) launched in 2017. Since the site was recently revamped, we wanted to spotlight the new available tools and resources that can help you better plan the design, conduct, and analysis of rigorous NIH-defined clinical trials.
In a previous post, we looked at the gender distribution of designated principal investigators (PI’s) of R01 and RPG applications submitted before and after the onset of the COVID-19 pandemic. Here we look at NIH R01 and RPG application patterns for January 1 through April 8 over the past 6 years; these applications patterns may well reflect longer-term pandemic effects.
An NIH peer reviewer was approached by a well-known professional grant writing service to assist a client in preparing an NIH grant application. The service advertised phenomenal success in securing NIH funding for its clients. What would you do? …
If you need to submit a Federal Financial Report (FFR) through the HHS Payment Management System (PMS), then you’ll want to be aware of two recent notices in the NIH Guide for Grants and Contracts.
NIH recently released its updated Strategic Plan for COVID-19 Research, available on the NIH COVID-19 website. Responses to a Request for Information helped inform this iteration, building on progress since the 2020 plan. The updated strategic plan highlights progress made in the development of diagnostics, therapeutics, and vaccines, along with developing strategies on how to effectively provide these resources.
As announced in March, updated biosketch and other support format pages and instructions are available for use in applications, Just-in-Time (JIT) Reports, and Research Performance Progress Reports (RPPRs). Use of the new format pages is preferred immediately and required for due dates and submissions on or after January 25, 2022. This represents a change from the original May 25, 2021 requirement date for the updated formats and other support signatures. Applicants and recipients can use this time to align their systems and processes with the new formats and instructions. Failure to follow the appropriate formats on or after January 25, 2022 may cause NIH to withdraw applications from or delay consideration of funding.